RBC raises Johnson & Johnson stock target to USD 290

Johnson & Johnson (ISIN US4781601046) stock was at EUR 225.58 at Lang & Schwarz on October 8, 2026 at 4:33 p.m. CEST, down 2.70 percent versus the prior close of EUR 231.83. According to TipRanks on October 6, 2026, RBC Capital raised its target from USD 287.00 to USD 290.00 and kept an Outperform rating.

Three dated developments

On July 15, 2026, Johnson & Johnson reported second-quarter revenue of USD 25.31 billion and earnings per share of USD 2.90, beating consensus by USD 0.06, according to MarketBeat. On September 21, 2026, Johnson & Johnson reported that CAPLYTA reduced symptoms of bipolar mania as early as Day 3, with benefits sustained through Week 3. The October 6 RBC action is the latest dated development, with the USD 3.00 target increase placing the new target 1.05 percent above the old one.

What does the target change signal?

RBC's note tied its higher target to quarterly sales estimates 1.00 percent above consensus, while also citing competitive pressure and geopolitical headwinds in electrophysiology, according to TipRanks. That combination matters because the target increase rests on operating estimates rather than a simple valuation re-rating.

Guggenheim separately reiterated a Buy rating and a USD 287.00 target on October 7, 2026, while projecting third-quarter revenue of USD 25.49 billion against consensus of USD 25.37 billion, as Investing.com reported. Its earnings per share forecast of USD 2.49 was below the USD 2.69 consensus, giving investors a clear counterweight to the favorable sales view.

Results date is October 13

Johnson & Johnson is scheduled to publish third-quarter 2026 results on October 13, 2026, according to The Wall Street Journal. The next report will test whether the sales momentum seen in the second quarter can support the analyst targets while earnings expectations remain more restrained.

Johnson and Johnson stock after the drop

At Lang & Schwarz, Johnson & Johnson stock was at EUR 225.58 on October 8, 2026 at 4:33 p.m. CEST, down 2.70 percent from the EUR 231.83 prior close. The primary listing is on the NYSE, where the finance quote showed USD 253.41 at 2:37 p.m. UTC on October 8, 2026, down 1.95 percent in its own currency; the 52-week range was USD 184.66 to USD 281.07 and market capitalization was USD 610.7 billion. The further course of trading is shown by the continuously updated real-time quote of Johnson & Johnson stock.

Market context: Market report S&P 500.

More news and analyses on Johnson & Johnson stock